Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inherited lung cancer: a review.
de Alencar VTL, Formiga MN, de Lima VCC. de Alencar VTL, et al. Among authors: de lima vcc. Ecancermedicalscience. 2020 Jan 29;14:1008. doi: 10.3332/ecancer.2020.1008. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32104210 Free PMC article. Review.
BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Brianese RC, Nakamura KDM, Almeida FGDSR, Ramalho RF, Barros BDF, Ferreira ENE, Formiga MNDC, de Andrade VP, de Lima VCC, Carraro DM. Brianese RC, et al. Among authors: de lima vcc, de andrade vp. Breast Cancer Res Treat. 2018 Feb;167(3):803-814. doi: 10.1007/s10549-017-4552-6. Epub 2017 Nov 7. Breast Cancer Res Treat. 2018. PMID: 29116469
Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer.
Parra ER, Jiang M, Machado-Rugolo J, Yaegashi LB, Prieto T, Farhat C, de Sá VK, Nagai MA, de Lima VCC, Takagaki T, Terra R, Fabro AT, Capelozzi VL. Parra ER, et al. Among authors: de lima vcc, de sa vk. Arch Pathol Lab Med. 2020 Oct 1;144(10):1234-1244. doi: 10.5858/arpa.2019-0419-OA. Arch Pathol Lab Med. 2020. PMID: 32150457 Free article.
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer.
de Moura Leite L, Cesca MG, Tavares MC, Santana DM, Saldanha EF, Guimarães PT, Sá DDS, Simões MFE, Viana RL, Rocha FG, Loose SK, Silva SF, Pirolli R, Fogassa CAZ, Mattos BRS, Campos FAB, Sanches SM, de Lima VCC, Pondé NF. de Moura Leite L, et al. Among authors: de lima vcc. Breast Cancer Res Treat. 2021 Nov;190(1):155-163. doi: 10.1007/s10549-021-06365-7. Epub 2021 Aug 18. Breast Cancer Res Treat. 2021. PMID: 34409551
Rhabdomyosarcomatous Transformation as a Mechanism of Resistance to Osimertinib and Savolitinib in EGFR-Mutant Lung Adenocarcinoma With METamp After Osimertinib First-Line Treatment.
Corassa M, Abreu RF, de Lima VCC, Torrezan GT, Cavalher FP, Silva TN, Oliveira TB, Freitas HC, Carraro DM, Costa FD. Corassa M, et al. Among authors: de lima vcc. JCO Precis Oncol. 2022 Oct;6:e2200367. doi: 10.1200/PO.22.00367. JCO Precis Oncol. 2022. PMID: 36201715 No abstract available.
36 results